Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.

Yi-Hsuan HuangMeei-Shyuan LeeYu-Sheng LouHou-Chuan LaiJyh-Cherng YuChueng-He LuChih-Shung WongWei-Hung Chan

Published in: PloS one (2019)

In our non-randomized retrospective analysis, neither propofol nor desflurane anesthesia for breast cancer surgery by an experienced surgeon can affect patient prognosis and survival. The influence of propofol anesthesia on breast cancer outcome requires further investigation.

Keyphrases

minimally invasive
coronary artery bypass
open label
double blind
free survival
surgical site infection
high dose
randomized controlled trial
young adults
coronary artery disease
acute coronary syndrome
breast cancer risk
percutaneous coronary intervention